Molecular landmarks of tumor hypoxia across cancer types-Reference-Cited by-同舟云学术

Molecular landmarks of tumor hypoxia across cancer types

Published:2019-01-14 Issue:2 Volume:51 Page:308-318
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Bhandari Vinayak^ORCID,Hoey Christianne^ORCID,Liu Lydia Y.,Lalonde Emilie,Ray Jessica^ORCID,Livingstone Julie^ORCID,Lesurf Robert,Shiah Yu-Jia^ORCID,Vujcic Tina,Huang Xiaoyong,Espiritu Shadrielle M. G.,Heisler Lawrence E.,Yousif Fouad,Huang Vincent^ORCID,Yamaguchi Takafumi N.^ORCID,Yao Cindy Q.,Sabelnykova Veronica Y.,Fraser Michael,Chua Melvin L. K.,van der Kwast Theodorus,Liu Stanley K.^ORCID,Boutros Paul C.^ORCID,Bristow Robert G.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/s41588-018-0318-2.pdf

Reference85 articles.

1. Wilson, W. R. & Hay, M. P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 11, 393–410 (2011).

2. Harris, A. L. Hypoxia: a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38–47 (2002).

3. Bristow, R. G. & Hill, R. P. Hypoxia and metabolism: hypoxia, DNA repair and genetic instability. Nat. Rev. Cancer 8, 180–192 (2008).

4. Weber, C. E. & Kuo, P. C. The tumor microenvironment. Surg. Oncol. 21, 172–177 (2012).

5. Blagosklonny, M. V. Antiangiogenic therapy and tumor progression. Cancer Cell. 5, 13–17 (2004).

Cited by 485 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AIEgen-functionalized nanoprobes and nanomedicines for cancer diagnosis and therapy;Coordination Chemistry Reviews;2024-12

2. Imaging Modalities for Head and Neck Cancer;Surgical Oncology Clinics of North America;2024-10

3. Emerging role of tumor microenvironmental nutrients and metabolic molecules in ferroptosis: Mechanisms and clinical implications;Biomedicine & Pharmacotherapy;2024-10

4. Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets;Molecular Cancer;2024-09-02

5. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02